Cargando…

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study

BACKGROUND: English cervical screening programme guidelines changed between 2009 and 2012. We explore the impact on the age and intervals at which women receive a cytology test. METHODS: Eligible women were controls from a population-based case–control study in England. Tests taken between 1980 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Sheikh, Shama, Pearmain, Philippa, Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366121/ https://www.ncbi.nlm.nih.gov/pubmed/32862772 http://dx.doi.org/10.1177/0969141320953446

Ejemplares similares

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review
por: Castanon, Alejandra, et al.
Publicado: (2021)

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study
por: Castanon, Alejandra, et al.
Publicado: (2012)

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Technological advances: Have they improved standards? Review of outcomes from the Welsh cervical screening programme
por: Castanon, Alejandra
Publicado: (2020)

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
por: Sasieni, P. D., et al.
Publicado: (1996)

Testing key messages about extending cervical screening intervals
por: A.V. Marlow, Laura, et al.
Publicado: (2022)

The impact of offering multiple cervical screening options to women whose screening was overdue in Dumfries and Galloway, Scotland
por: Wedisinghe, L., et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries
por: Castanon, Alejandra, et al.
Publicado: (2017)

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study
por: Li, Shuping J., et al.
Publicado: (2022)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
por: Zeferino, Luiz Carlos, et al.
Publicado: (2018)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
por: Iftner, Thomas, et al.
Publicado: (2019)

Acceptability of non-speculum clinician sampling for cervical screening in older women: A qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2018)

Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007–2016
por: Sayed, Sayeeda Amber, et al.
Publicado: (2020)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

The effect of Pap smear screening on cervical cancer stage among southern Thai women
por: Niu, Li, et al.
Publicado: (2019)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ier4kompk4h6s1qkelsghrqll8